How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?
AMA J Ethics. 2020; 22(1):E43-49. doi:
10.1001/amajethics.2020.43.
Aminu Yakubu, Nchangwi Syntia Munung, and Jantina De Vries, PhD
African cancer research is embedded in underresourced health care infrastructures, illuminating ethical questions about benefit sharing and governance.
AMA J Ethics. 2020; 22(2):E156-163. doi:
10.1001/amajethics.2020.156.
In this special edition of Ethics Talk, Dr Uché Blackstock joins us to discuss COVID-19 morbidity and mortality outcomes inequity by race and what needs to change now and postpandemic. Transcript available.
Jennifer D. Byrne, LCSW, CADC, Katie S. Clancy, MSW, and Isabell Ciszewski, LCSW
Social work perspectives on whether prescribers should authorize opioid refills emphasize the importance of multidisciplinary approaches to patient self-determination.
AMA J Ethics. 2020; 22(8):E658-663. doi:
10.1001/amajethics.2020.658.
Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful.
AMA J Ethics. 2020; 22(8):E723-728. doi:
10.1001/amajethics.2020.723.